Literature DB >> 10816383

Spontaneously regressing oral papillomas induce systemic antibodies that neutralize canine oral papillomavirus.

S Ghim1, J Newsome, J Bell, J P Sundberg, R Schlegel, A B Jenson.   

Abstract

Canine oral papillomavirus (COPV) infection of naive beagle dogs causes oral papillomas, most of which spontaneously regress. Regressor beagles do not develop new oral papillomas because of COPV type-specific, cell-mediated immunity, COPV neutralizing antibodies, or both. Formalin-fixed native and recombinant COPV vaccines that target the systemic immune system induce neutralizing antibodies that prevent development of oral papillomas. This study was designed to determine whether spontaneously regressing mucosal papillomas also targeted the systemic immune system to induce circulating, neutralizing IgG antibodies that protect against infection by COPV. To accomplish this goal, IgG was fractionated from sera collected from weanling beagles and regressor beagles and tested for conferring protection by passive immunization. Serum was tested by ELISA for antibodies against intact virions and then pooled for passive transfer to naive beagles. Preimmune sera were neither reactive by ELISA nor protective by passive transfer. On the other hand, IgG antibodies from regressor beagles were reactive by ELISA and passive transfer conferred protection against COPV challenge. Circulating IgG antibodies induced by spontaneous regression of canine oral papillomas protect beagles against intraoral infection by COPV, a model for mucosotropic HPV. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10816383     DOI: 10.1006/exmp.1999.2298

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  21 in total

1.  Complete genome sequence of canine papillomavirus type 9.

Authors:  Hang Yuan; Jennifer Luff; Dan Zhou; Jingang Wang; Verena Affolter; Peter Moore; Richard Schlegel
Journal:  J Virol       Date:  2012-05       Impact factor: 5.103

Review 2.  Prophylactic HPV vaccines.

Authors:  Margaret Stanley
Journal:  J Clin Pathol       Date:  2007-01-26       Impact factor: 3.411

3.  Complete genome sequence of canine papillomavirus type 10.

Authors:  Jennifer Luff; Peter Moore; Dan Zhou; Jingang Wang; Yukari Usuda; Verena Affolter; Richard Schlegel; Hang Yuan
Journal:  J Virol       Date:  2012-10       Impact factor: 5.103

4.  HPV vaccines: Translating immunogenicity into efficacy.

Authors:  Taylor B Turner; Warner K Huh
Journal:  Hum Vaccin Immunother       Date:  2015-10-29       Impact factor: 3.452

5.  Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.

Authors:  Marc Arbyn; Andrew Bryant; Philippe Beutels; Pierre Pl Martin-Hirsch; Evangelos Paraskevaidis; Elke Van Hoof; Marc Steben; Youlin Qiao; Fang-Hui Zhao; Achim Schneider; Andreas Kaufmann; Joakim Dillner; Lauri Markowitz; Allan Hildesheim
Journal:  Cochrane Database Syst Rev       Date:  2011

Review 6.  [Prophylactic and therapeutic vaccines against human papilloma virus].

Authors:  A E Albers; T K Hoffmann; J P Klussmann; A M Kaufmann
Journal:  HNO       Date:  2010-08       Impact factor: 1.284

7.  Skin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model.

Authors:  Holly J Corbett; Germain J P Fernando; Xianfeng Chen; Ian H Frazer; Mark A F Kendall
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

8.  Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses.

Authors:  Alba-Lucia Combita; Antoine Touzé; Latifa Bousarghin; Neil D Christensen; Pierre Coursaget
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

9.  Multicenter initiative seeking critical genes in respiratory papillomatosis.

Authors:  Farrel J Buchinsky; Craig S Derkay; Suzanne M Leal; Joseph Donfack; Garth D Ehrlich; J Christopher Post
Journal:  Laryngoscope       Date:  2004-02       Impact factor: 3.325

10.  Detection of antibodies against epidermodysplasia verruciformis-associated canine papillomavirus 3 in sera of dogs from Europe and Africa by enzyme-linked immunosorbent assay.

Authors:  C E Lange; K Tobler; C Favrot; M Müller; J O Nöthling; M Ackermann
Journal:  Clin Vaccine Immunol       Date:  2008-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.